NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/12/2024
Voltar para busca
Dado oficial do USPTO
MAPLAB
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
17/12/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
20/09/2023
Data de registro
17/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/12/2024
Última transação
17/12/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
23/09/2023
Primeiro uso no comércio
23/09/2023
Código do desenho
4
Tipo de titular
03
Localização do titular
San Francisco, CA
Examinador
RENNEKER, CHRISTOPHER JOHN
Unidade examinadora
M40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Komodo Health, Inc.
Representantes
Jordan A. LaVine FLASTER GREENBERG PC
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business data collection and analysis services in the field of healthcareaggregatingorganizing and compiling of informationdatastatisticsinsightsmetricsprofilesanalytics and intelligence on healthcare industry demographicspractitioner demographicspatient demographicspatient therapies and treatmentsprescriptionspatient flows and referral pathwaysdisease demographicscare demographicslab dataclinical study and trial demographicshealthcare behaviorscostsoutcomespayer datascientific publicationsall of the foregoing excluding psychedelic medicines and therapies; business consulting and analysis services regarding informationdatastatisticsinsightsmetricsprofilesanalytics and intelligence on healthcare industry demographicspractitioner demographicspatient demographicspatient therapies and treatmentsprescriptionspatient flows and referral pathwaysdisease demographicscare demographicslab dataclinical study and trial demographicshealthcare behaviorscostsoutcomespayer datascientific publicationsall of the foregoing excluding psychedelic medicines and therapies; Providing business information in the field of the healthcare and life sciences industriesall of the foregoing excluding psychedelic medicines and therapies; Business consulting services to businesses in the healthcare and life sciences industriesall of the foregoing excluding psychedelic medicines and therapies
Classe 42
Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare viewing of a database with informationdatastatisticsinsightsmetricsprofilesanalytics and intelligence on healthcare industry demographicspractitioner demographicspatient demographicspatient therapies and treatmentsprescriptionspatient flows and referral pathwaysdisease demographicscare demographicslab dataclinical study and trial demographicshealthcare behaviorscostsoutcomespayer datascientific publicationsall of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare the ability to model patient journeyspathwayscare programsall of the foregoing excluding psychedelic medicines and therapies; computer servicesdatabase development servicesconfiguration and customization of databases containing informationdatastatisticsinsightsmetricsprofilesanalytics and intelligence healthcare industry demographicspractitioner demographicspatient demographicspatient therapies and treatmentsprescriptionspatient flows and referral pathwaysdisease demographicslab datacare demographicsclinical study and trial demographicshealthcare behaviorscostsoutcomespayer datascientific publicationsall of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (paas) featuring computer software platforms that allow the viewing of market access insights to the life sciences industryprovide business solutions that unify pharmaceutical salesoperationsmarketing dataprovide data intelligence that aids with effective targetingmessaginginitiatives driving sales performanceall of the foregoing excluding psychedelic medicines and therapies; Designdevelopment and implementation of computer software for the healthcare and life sciences industrythe design and development of cloud-based and application-based software for monitoringmarketingdelivering products in the healthcare and life sciences industryall of the foregoing excluding psychedelic medicines and therapies; Consulting services in the fields of selectionimplementation and use of computer hardware and software systems for others in the health care and life science industriesall of the foregoing excluding psychedelic medicines and therapies; Business technology software consultation services in the health care and life science industriesall of the foregoing excluding psychedelic medicines and therapies; Software development and product development consulting in the field of the health care and life science industriesall of the foregoing excluding psychedelic medicines and therapies
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
17/12/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
26/11/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
26/11/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
22/11/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
22/11/2024
IUAF
USE AMENDMENT FILED
18/09/2024
EISU
TEAS STATEMENT OF USE RECEIVED
18/09/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
20/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/06/2024
PUBO
PUBLISHED FOR OPPOSITION
25/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/05/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
22/05/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
22/05/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/05/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
22/05/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/05/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/05/2024
GNRT
NON-FINAL ACTION E-MAILED
14/05/2024
CNRT
NON-FINAL ACTION WRITTEN
14/05/2024
DOCK
ASSIGNED TO EXAMINER
14/05/2024
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
01/11/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
01/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/10/2023
NWAP
NEW APPLICATION ENTERED
23/09/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MAPLAB ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.